143 related articles for article (PubMed ID: 3604469)
1. A fatal case of sulindac-induced Lyell syndrome (toxic epidermal necrolysis).
Ikeda N; Umetsu K; Suzuki T
Z Rechtsmed; 1987; 98(2):141-6. PubMed ID: 3604469
[TBL] [Abstract][Full Text] [Related]
2. Sulindac-induced Stevens-Johnson toxic epidermal necrolysis syndrome.
Levitt L; Pearson RW
JAMA; 1980 Mar; 243(12):1262-3. PubMed ID: 7359684
[No Abstract] [Full Text] [Related]
3. Hepatitis, toxic epidermal necrolysis and pancreatitis in association with sulindac therapy.
Klein SM; Khan MA
J Rheumatol; 1983 Jun; 10(3):512-3. PubMed ID: 6224935
[TBL] [Abstract][Full Text] [Related]
4. Stevens-Johnson syndrome due to sulindac: a case report and review of the literature.
Maguire FW
Del Med J; 1981 Apr; 53(4):193-7. PubMed ID: 7227578
[No Abstract] [Full Text] [Related]
5. Sulindac-induced Stevens-Johnson syndrome: report of 3 cases.
Husain Z; Runge LA; Jabbs JM; Hyla JA
J Rheumatol; 1981; 8(1):176-9. PubMed ID: 7218253
[No Abstract] [Full Text] [Related]
6. Use of infliximab in toxic epidermal necrolysis: a still opened challenge.
Ganzetti G; Campanati A; Simonetti O; Giuliodori K; Giangiacomi M; Lemme G; Offidani A
G Ital Dermatol Venereol; 2015 Aug; 150(4):467-71. PubMed ID: 25394212
[TBL] [Abstract][Full Text] [Related]
7. [Lyell syndrome or toxic epidermal necrolysis and Stevens-Johnson syndrome after treatment with fluoxetine].
Bodokh I; Lacour JP; Rosenthal E; Chichmanian RM; Perrin C; Vitetta A; Ortonne JP
Therapie; 1992; 47(5):441. PubMed ID: 1299992
[No Abstract] [Full Text] [Related]
8. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
[TBL] [Abstract][Full Text] [Related]
9. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
[TBL] [Abstract][Full Text] [Related]
10. Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Halted by Etanercept.
Gavigan GM; Kanigsberg ND; Ramien ML
J Cutan Med Surg; 2018; 22(5):514-515. PubMed ID: 29421925
[TBL] [Abstract][Full Text] [Related]
11. Ofloxacin: a probable cause of toxic epidermal necrolysis.
Melde SL
Ann Pharmacother; 2001 Nov; 35(11):1388-90. PubMed ID: 11724089
[TBL] [Abstract][Full Text] [Related]
12. [Development of Stevens-Johnson syndrome following sulindac administration in a patient with mixed connective tissue disease].
Awaya N; Fujii T; Akizuki M
Ryumachi; 1993 Oct; 33(5):432-6. PubMed ID: 8256166
[TBL] [Abstract][Full Text] [Related]
13. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
Assaad D; From L; Ricciatti D; Shapero H
Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383
[TBL] [Abstract][Full Text] [Related]
14. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
[TBL] [Abstract][Full Text] [Related]
15. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].
Aberer W; Stingl G; Wolff K
Hautarzt; 1982 Sep; 33(9):484-90. PubMed ID: 7174320
[TBL] [Abstract][Full Text] [Related]
16. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Mockenhaupt M
Expert Rev Clin Immunol; 2011 Nov; 7(6):803-13; quiz 814-5. PubMed ID: 22014021
[TBL] [Abstract][Full Text] [Related]
17. [Severe skin reactions. Toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema exsudativum multiforme majus and generalized bullous fixed drug exanthema].
Rzany B; Mockenhaupt M; Baur S; Stocker U; Schöpf E
Hautarzt; 1993 Aug; 44(8):549-54; quiz 554-6. PubMed ID: 8376113
[No Abstract] [Full Text] [Related]
18. Fatal toxic epidermal necrolysis induced by carbamazepine treatment in a patient who previously had carbamazepine-induced Stevens-Johnson syndrome.
Huang LY; Liao WC; Chiou CC; Lou JP; Hu P; Ko FC
J Formos Med Assoc; 2007 Dec; 106(12):1032-7. PubMed ID: 18194909
[TBL] [Abstract][Full Text] [Related]
19. Sulindac-induced toxic epidermal necrolysis.
Small RE; Garnett WR
Clin Pharm; 1988 Oct; 7(10):766-71. PubMed ID: 3233897
[TBL] [Abstract][Full Text] [Related]
20. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
